Lawsuit Overview
Sept. 28, 2012 (Shareholders Foundation) -- An investor in shares of Complete Genomics, Inc. (NASDAQ:GNOM) filed a lawsuit against directors of Complete Genomics in effort to block the proposed takeover at $3.15 per NASDAQ:GNOM. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:GNOM investors arising out of their attempt to sell the company too ...
You must register (for free) or login to view the entire case.